A carregar...
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential
Severe asthma is characterized by major impairment of quality of life, poor symptom control and frequent exacerbations. Inflammatory, clinical and causative factors identify different phenotypes and endotypes of asthma. In the last few years, new treatment options have allowed for targeted treatment...
Na minha lista:
| Publicado no: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076744/ https://ncbi.nlm.nih.gov/pubmed/27803792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316659863 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|